(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYP27A1 mRNA] CTD PMID:31150632 (1->4)-beta-D-glucan multiple interactions ISO RGD:1550475 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CYP27A1 mRNA CTD PMID:36331819 (24S)-24-hydroxycholesterol decreases abundance ISO RGD:1346613 6480464 CYP27A1 protein results in decreased abundance of 24-hydroxycholesterol CTD PMID:12119285 (25R)-cholest-5-ene-3beta,26-diol increases abundance ISO RGD:1346613 6480464 CYP27A1 protein results in increased abundance of 27-hydroxycholesterol CTD PMID:12119285 (25R)-cholest-5-ene-3beta,26-diol multiple interactions EXP 6480464 [CYP27A1 protein results in increased metabolism of Cholesterol] which results in increased chemical synthesis of 27-hydroxycholesterol CTD PMID:8496670 (25R)-cholest-5-ene-3beta,26-diol increases chemical synthesis ISO RGD:1346613 6480464 CYP27A1 protein results in increased chemical synthesis of 27-hydroxycholesterol CTD PMID:11714861 more ... (25R)-cholest-5-ene-3beta,26-diol multiple interactions ISO RGD:1346613 6480464 [[CYP27A1 protein results in increased metabolism of Cholesterol] which results in increased chemical synthesis of 27-hydroxycholesterol] which results in increased activity of HMGCR protein more ... CTD PMID:11408283 more ... (5alpha)-cholestan-3beta-ol increases secretion ISO RGD:1346613 6480464 CYP27A1 protein results in increased secretion of Cholestanol CTD PMID:12117727 (S)-amphetamine decreases expression EXP 6480464 Dextroamphetamine results in decreased expression of CYP27A1 mRNA CTD PMID:16715494 1,2,3-trilinolenoylglycerol decreases expression ISO RGD:1550475 6480464 trilinolenin results in decreased expression of CYP27A1 mRNA CTD PMID:18356535 1,2,3-trilinoleoylglycerol decreases expression ISO RGD:1550475 6480464 trilinolein results in decreased expression of CYP27A1 mRNA CTD PMID:18356535 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of CYP27A1 mRNA CTD PMID:24120425 1-naphthyl isothiocyanate decreases expression ISO RGD:1550475 6480464 1-Naphthylisothiocyanate results in decreased expression of CYP27A1 mRNA CTD PMID:25655198 , PMID:30517764 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of CYP27A1 mRNA CTD PMID:16174780 , PMID:17108234 17alpha-ethynylestradiol multiple interactions ISO RGD:1550475 6480464 [Ethinyl Estradiol co-treated with Metformin] results in decreased expression of CYP27A1 mRNA, [Metformin co-treated with Ethinyl Estradiol] results in decreased expression of CYP27A1 protein CTD PMID:34058177 17alpha-ethynylestradiol decreases expression ISO RGD:1550475 6480464 Ethinyl Estradiol results in decreased expression of CYP27A1 mRNA, Ethinyl Estradiol results in decreased expression of CYP27A1 protein CTD PMID:34058177 17alpha-ethynylestradiol multiple interactions ISO RGD:1346613 6480464 [Ethinyl Estradiol co-treated with Cholic Acids] affects the expression of CYP27A1 mRNA CTD PMID:27344345 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of CYP27A1 mRNA CTD PMID:32145629 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1550475 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1346613 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP27A1 mRNA CTD PMID:12377990 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CYP27A1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1550475 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP27A1 mRNA CTD PMID:28213091 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP27A1 mRNA CTD PMID:21215274 , PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1550475 6480464 Tetrachlorodibenzodioxin affects the expression of CYP27A1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1550475 6480464 [NFE2L2 gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CYP27A1 mRNA more ... CTD PMID:21846477 more ... 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of CYP27A1 mRNA CTD PMID:21346803 2-arachidonoylglycerol multiple interactions ISO RGD:1346613 6480464 CNR1 gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CYP27A1 mRNA] more ... CTD PMID:23894352 2-arachidonoylglycerol increases expression ISO RGD:1346613 6480464 glyceryl 2-arachidonate results in increased expression of CYP27A1 mRNA CTD PMID:23894352 2-arachidonoylglycerol multiple interactions ISO RGD:1550475 6480464 CNR1 gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CYP27A1 mRNA] CTD PMID:23894352 2-arachidonoylglycerol increases expression ISO RGD:1550475 6480464 glyceryl 2-arachidonate results in increased expression of CYP27A1 mRNA CTD PMID:23894352 , PMID:28095641 25-hydroxycholesterol multiple interactions ISO RGD:1346613 6480464 [CYP27A1 protein results in increased metabolism of Cholesterol] which results in increased chemical synthesis of 25-hydroxycholesterol CTD PMID:8078928 25-hydroxycholesterol increases chemical synthesis ISO RGD:1550475 6480464 CYP27A1 protein results in increased chemical synthesis of 25-hydroxycholesterol CTD PMID:17890683 26-hydroxycholesterol multiple interactions EXP 6480464 [CYP27A1 protein results in increased metabolism of Cholesterol] which results in increased chemical synthesis of 27-hydroxycholesterol CTD PMID:8496670 26-hydroxycholesterol increases chemical synthesis ISO RGD:1346613 6480464 CYP27A1 protein results in increased chemical synthesis of 27-hydroxycholesterol CTD PMID:11714861 more ... 26-hydroxycholesterol multiple interactions ISO RGD:1346613 6480464 [[CYP27A1 protein results in increased metabolism of Cholesterol] which results in increased chemical synthesis of 27-hydroxycholesterol] which results in increased activity of HMGCR protein more ... CTD PMID:11408283 more ... 26-hydroxycholesterol increases abundance ISO RGD:1346613 6480464 CYP27A1 protein results in increased abundance of 27-hydroxycholesterol CTD PMID:12119285 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:1550475 6480464 3 more ... CTD PMID:19467301 3beta-hydroxycholest-5-en-26-oic acid increases chemical synthesis ISO RGD:1346613 6480464 CYP27A1 protein results in increased chemical synthesis of 3-hydroxy-5-cholestenoic acid CTD PMID:14622972 3beta-hydroxycholest-5-en-26-oic acid multiple interactions ISO RGD:1346613 6480464 [CYP27A1 protein results in increased metabolism of Cholesterol] which results in increased chemical synthesis of 3-hydroxy-5-cholestenoic acid, [CYP27A1 protein results in increased oxidation of 27-hydroxycholesterol] which results in increased chemical synthesis of 3-hydroxy-5-cholestenoic acid CTD PMID:8078928 more ... 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1550475 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of CYP27A1 mRNA CTD PMID:18648102 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of CYP27A1 mRNA CTD PMID:24780913 more ... 7-ketocholesterol increases metabolic processing ISO RGD:1346613 6480464 CYP27A1 protein results in increased metabolism of 7-ketocholesterol CTD PMID:10869358 8-Br-cAMP decreases expression ISO RGD:1346613 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CYP27A1 mRNA CTD PMID:22079614 9-cis-retinoic acid increases expression ISO RGD:1346613 6480464 Alitretinoin results in increased expression of CYP27A1 mRNA CTD PMID:15964820 9-cis-retinoic acid decreases expression ISO RGD:1346613 6480464 Alitretinoin results in decreased expression of CYP27A1 mRNA CTD PMID:15982314 9-cis-retinoic acid multiple interactions ISO RGD:1346613 6480464 Dimethyl Sulfoxide promotes the reaction [Alitretinoin results in increased expression of CYP27A1 mRNA], periodate-oxidized adenosine inhibits the reaction [Dimethyl Sulfoxide promotes the reaction [Alitretinoin results in increased expression of CYP27A1 mRNA]] CTD PMID:15964820 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of CYP27A1 mRNA CTD PMID:31881176 acrylamide increases expression ISO RGD:1550475 6480464 Acrylamide results in increased expression of CYP27A1 mRNA CTD PMID:30807115 aflatoxin B1 decreases expression ISO RGD:1346613 6480464 Aflatoxin B1 results in decreased expression of CYP27A1 mRNA CTD PMID:27153756 all-trans-4-oxoretinoic acid decreases expression ISO RGD:1346613 6480464 4-oxoretinoic acid results in decreased expression of CYP27A1 mRNA CTD PMID:15982314 AM-251 multiple interactions ISO RGD:1550475 6480464 AM 251 inhibits the reaction [Ethanol results in increased expression of CYP27A1 mRNA] CTD PMID:23894352 , PMID:28095641 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CYP27A1 mRNA CTD PMID:16483693 amphotericin B multiple interactions ISO RGD:1550475 6480464 [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA], [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA CTD PMID:36464106 ampicillin multiple interactions ISO RGD:1550475 6480464 [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA], [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA CTD PMID:36464106 arsane affects methylation ISO RGD:1346613 6480464 Arsenic affects the methylation of CYP27A1 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1346613 6480464 Arsenic affects the methylation of CYP27A1 gene CTD PMID:25304211 atazanavir sulfate multiple interactions ISO RGD:1346613 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of CYP27A1 mRNA CTD PMID:33819548 atorvastatin calcium decreases expression ISO RGD:1346613 6480464 Atorvastatin results in decreased expression of CYP27A1 mRNA, Atorvastatin results in decreased expression of CYP27A1 protein CTD PMID:16386711 atorvastatin calcium increases expression ISO RGD:1550475 6480464 Atorvastatin results in increased expression of CYP27A1 mRNA CTD PMID:25278499 atrazine increases expression ISO RGD:1346613 6480464 Atrazine results in increased expression of CYP27A1 mRNA CTD PMID:22378314 Augmentin decreases expression ISO RGD:1346613 6480464 Amoxicillin-Potassium Clavulanate Combination results in decreased expression of CYP27A1 mRNA CTD PMID:34767876 benzalkonium chloride decreases expression ISO RGD:1346613 6480464 Benzalkonium Compounds results in decreased expression of CYP27A1 mRNA CTD PMID:20713136 benzene-1,2,4-triol increases expression ISO RGD:1346613 6480464 hydroxyhydroquinone results in increased expression of CYP27A1 mRNA CTD PMID:17572062 benzo[a]pyrene affects expression ISO RGD:1550475 6480464 Benzo(a)pyrene affects the expression of CYP27A1 mRNA CTD PMID:20127859 benzo[a]pyrene decreases expression ISO RGD:1346613 6480464 Benzo(a)pyrene results in decreased expression of CYP27A1 mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:1346613 6480464 Benzo(a)pyrene results in increased methylation of CYP27A1 5' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1550475 6480464 Benzo(a)pyrene results in increased expression of CYP27A1 mRNA, Benzo(a)pyrene results in increased expression of CYP27A1 protein CTD PMID:22228805 , PMID:34472326 beta-hexachlorocyclohexane increases expression ISO RGD:1346613 6480464 beta-hexachlorocyclohexane results in increased expression of CYP27A1 mRNA CTD PMID:28392238 beta-hexachlorocyclohexane increases expression ISO RGD:1550475 6480464 beta-hexachlorocyclohexane results in increased expression of CYP27A1 mRNA CTD PMID:28392238 beta-naphthoflavone increases expression ISO RGD:1346613 6480464 beta-Naphthoflavone results in increased expression of CYP27A1 mRNA CTD PMID:32151702 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of CYP27A1 mRNA CTD PMID:16648578 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of CYP27A1 mRNA CTD PMID:26472102 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CYP27A1 mRNA CTD PMID:25181051 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CYP27A1 mRNA CTD PMID:32145629 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CYP27A1 mRNA CTD PMID:30903817 bisphenol A increases expression ISO RGD:1346613 6480464 bisphenol A results in increased expression of CYP27A1 mRNA CTD PMID:27685785 , PMID:29275510 buspirone increases expression EXP 6480464 Buspirone results in increased expression of CYP27A1 mRNA CTD PMID:24136188 Butylbenzyl phthalate increases expression EXP 6480464 butylbenzyl phthalate results in increased expression of CYP27A1 mRNA CTD PMID:26472102 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of CYP27A1 mRNA CTD PMID:19167457 caesium atom increases activity EXP 6480464 Cesium results in increased activity of CYP27A1 protein CTD PMID:20173315 calciol affects expression EXP 6480464 Cholecalciferol affects the expression of CYP27A1 mRNA CTD PMID:21843606 calcitriol increases expression EXP 6480464 Calcitriol results in increased expression of CYP27A1 protein CTD PMID:8164439 calcitriol decreases expression ISO RGD:1346613 6480464 Calcitriol results in decreased expression of CYP27A1 mRNA CTD PMID:26485663 carbon nanotube decreases expression ISO RGD:1550475 6480464 Nanotubes more ... CTD PMID:25620056 CGS-21680 multiple interactions ISO RGD:1346613 6480464 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of CYP27A1 mRNA], 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of CYP27A1 protein] CTD PMID:19035488 chenodeoxycholic acid decreases expression EXP 6480464 Chenodeoxycholic Acid results in decreased expression of CYP27A1 mRNA CTD PMID:7832767 chenodeoxycholic acid multiple interactions ISO RGD:1550475 6480464 Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in decreased expression of CYP27A1 mRNA], Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in decreased expression of CYP27A1 protein] CTD PMID:35780845 chenodeoxycholic acid multiple interactions ISO RGD:1346613 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP27A1 mRNA more ... CTD PMID:33819548 chenodeoxycholic acid decreases expression ISO RGD:1550475 6480464 Chenodeoxycholic Acid results in decreased expression of CYP27A1 mRNA CTD PMID:25582706 cholesterol multiple interactions ISO RGD:1346613 6480464 [[CYP27A1 protein results in increased metabolism of Cholesterol] which results in increased chemical synthesis of 27-hydroxycholesterol] which results in increased activity of HMGCR protein more ... CTD PMID:11408283 more ... cholesterol multiple interactions EXP 6480464 [CYP27A1 protein results in increased metabolism of Cholesterol] which results in increased chemical synthesis of 27-hydroxycholesterol CTD PMID:8496670 cholesterol multiple interactions ISO RGD:1550475 6480464 [Cholesterol deficiency co-treated with Dietary Fats] results in decreased expression of CYP27A1 mRNA CTD PMID:18356535 cholesterol increases secretion ISO RGD:1346613 6480464 CYP27A1 protein results in increased secretion of Cholesterol CTD PMID:12117727 cholesterol decreases chemical synthesis ISO RGD:1346613 6480464 CYP27A1 protein results in decreased chemical synthesis of Cholesterol CTD PMID:12531903 cholic acid decreases expression EXP 6480464 Cholic Acid results in decreased expression of CYP27A1 mRNA CTD PMID:7832767 cholic acid decreases expression ISO RGD:1550475 6480464 Cholic Acid results in decreased expression of CYP27A1 mRNA CTD PMID:25582706 choline multiple interactions ISO RGD:1550475 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CYP27A1 mRNA CTD PMID:22872676 ciguatoxin CTX1B affects expression ISO RGD:1550475 6480464 Ciguatoxins affects the expression of CYP27A1 mRNA CTD PMID:18353800 clavulanic acid decreases expression ISO RGD:1346613 6480464 Clavulanic Acid results in decreased expression of CYP27A1 mRNA CTD PMID:34767876 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of CYP27A1 mRNA CTD PMID:17602206 copper(II) chloride increases expression ISO RGD:1550475 6480464 cupric chloride results in increased expression of CYP27A1 mRNA CTD PMID:17211630 copper(II) sulfate decreases expression ISO RGD:1346613 6480464 Copper Sulfate results in decreased expression of CYP27A1 mRNA CTD PMID:19549813 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of CYP27A1 mRNA CTD PMID:26577399 cyclosporin A multiple interactions ISO RGD:1346613 6480464 [Cyclosporine co-treated with Cholic Acids] affects the expression of CYP27A1 mRNA more ... CTD PMID:17516993 more ... cyclosporin A decreases expression ISO RGD:1346613 6480464 Cyclosporine results in decreased expression of CYP27A1 mRNA, Cyclosporine results in decreased expression of CYP27A1 protein CTD PMID:20106945 more ... cyclosporin A decreases activity ISO RGD:1346613 6480464 Cyclosporine results in decreased activity of CYP27A1 protein CTD PMID:17516993 cytarabine decreases expression ISO RGD:1346613 6480464 Cytarabine results in decreased expression of CYP27A1 mRNA CTD PMID:21198554 DDE increases expression ISO RGD:1346613 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of CYP27A1 mRNA CTD PMID:28392238 DDE increases expression ISO RGD:1550475 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of CYP27A1 mRNA CTD PMID:28392238 deoxycholic acid multiple interactions ISO RGD:1550475 6480464 SLCO1A1 protein affects the susceptibility to [Deoxycholic Acid results in decreased expression of CYP27A1 mRNA] CTD PMID:21914718 deoxycholic acid multiple interactions ISO RGD:1346613 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP27A1 mRNA more ... CTD PMID:33819548 deoxycholic acid decreases expression ISO RGD:1550475 6480464 Deoxycholic Acid results in decreased expression of CYP27A1 mRNA CTD PMID:21914718 , PMID:25582706 deoxycholic acid decreases expression EXP 6480464 Deoxycholic Acid results in decreased expression of CYP27A1 mRNA CTD PMID:7832767 desmosterol increases metabolic processing ISO RGD:1346613 6480464 CYP27A1 protein results in increased metabolism of Desmosterol CTD PMID:14622972 dexamethasone multiple interactions ISO RGD:1346613 6480464 Dexamethasone promotes the reaction [NR3C1 protein binds to CYP27A1 promoter] CTD PMID:18817892 dexamethasone increases expression ISO RGD:1346613 6480464 Dexamethasone results in increased expression of CYP27A1 mRNA CTD PMID:18817892 dibenzofurans increases expression ISO RGD:1550475 6480464 Dibenzofurans results in increased expression of CYP27A1 mRNA CTD PMID:34254344 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of CYP27A1 mRNA CTD PMID:21266533 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of CYP27A1 mRNA CTD PMID:26472102 dimethyl sulfoxide multiple interactions ISO RGD:1346613 6480464 Dimethyl Sulfoxide promotes the reaction [alitretinoin results in increased expression of CYP27A1 mRNA], periodate-oxidized adenosine inhibits the reaction [Dimethyl Sulfoxide promotes the reaction [alitretinoin results in increased expression of CYP27A1 mRNA]] CTD PMID:15964820 Diosbulbin B decreases expression ISO RGD:1550475 6480464 diosbulbin B results in decreased expression of CYP27A1 mRNA CTD PMID:32148032 diosgenin multiple interactions EXP 6480464 Diosgenin promotes the reaction [Dietary Fats results in increased expression of CYP27A1 mRNA] CTD PMID:33383043 dioxygen multiple interactions ISO RGD:1550475 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CYP27A1 mRNA CTD PMID:30529165 dipentyl phthalate increases expression EXP 6480464 di-n-pentyl phthalate results in increased expression of CYP27A1 mRNA CTD PMID:26472102 diquat increases expression ISO RGD:1550475 6480464 Diquat results in increased expression of CYP27A1 mRNA CTD PMID:36851058 disodium selenite multiple interactions ISO RGD:1550475 6480464 [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA] CTD PMID:36464106 diuron increases expression EXP 6480464 Diuron results in increased expression of CYP27A1 mRNA CTD PMID:21551480 elemental selenium multiple interactions ISO RGD:1550475 6480464 [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA] CTD PMID:36464106 emodin decreases expression EXP 6480464 Emodin results in decreased expression of CYP27A1 mRNA CTD PMID:28161596 emodin multiple interactions EXP 6480464 [2 more ... CTD PMID:35753641 emodin decreases expression ISO RGD:1550475 6480464 Emodin results in decreased expression of CYP27A1 mRNA CTD PMID:30517764 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of CYP27A1 mRNA CTD PMID:29391264 enilconazole increases expression ISO RGD:1550475 6480464 enilconazole results in increased expression of CYP27A1 mRNA CTD PMID:32814239 ethanol increases expression ISO RGD:1550475 6480464 Ethanol results in increased expression of CYP27A1 mRNA CTD PMID:23894352 , PMID:28095641 ethanol multiple interactions ISO RGD:1550475 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of CYP27A1 mRNA more ... CTD PMID:23894352 more ... eugenol decreases expression ISO RGD:1346613 6480464 Eugenol results in decreased expression of CYP27A1 mRNA CTD PMID:20713136 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of CYP27A1 mRNA CTD PMID:24136188 , PMID:24793618 folic acid multiple interactions ISO RGD:1550475 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CYP27A1 mRNA CTD PMID:22872676 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CYP27A1 mRNA CTD PMID:33387578 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of CYP27A1 mRNA CTD PMID:24136188 glycochenodeoxycholic acid multiple interactions ISO RGD:1346613 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP27A1 mRNA more ... CTD PMID:33819548 glycocholic acid multiple interactions ISO RGD:1346613 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP27A1 mRNA more ... CTD PMID:33819548 glycodeoxycholic acid multiple interactions ISO RGD:1346613 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP27A1 mRNA more ... CTD PMID:33819548 GW 4064 increases expression ISO RGD:1550475 6480464 GW 4064 results in increased expression of CYP27A1 mRNA CTD PMID:27609522 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of CYP27A1 mRNA CTD PMID:18299717 indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of CYP27A1 mRNA CTD PMID:36868495 irinotecan affects expression EXP 6480464 Irinotecan affects the expression of CYP27A1 mRNA CTD PMID:20097248 isoniazide increases expression EXP 6480464 Isoniazid results in increased expression of CYP27A1 mRNA CTD PMID:32673658 isotretinoin decreases expression ISO RGD:1346613 6480464 Isotretinoin results in decreased expression of CYP27A1 mRNA CTD PMID:15982314 ivermectin decreases expression ISO RGD:1346613 6480464 Ivermectin results in decreased expression of CYP27A1 protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:1550475 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CYP27A1 mRNA CTD PMID:22872676 lanosterol increases metabolic processing ISO RGD:1346613 6480464 CYP27A1 protein results in increased metabolism of Lanosterol CTD PMID:14622972 lead diacetate decreases expression ISO RGD:1550475 6480464 lead acetate results in decreased expression of CYP27A1 mRNA CTD PMID:21829687 levofloxacin increases expression EXP 6480464 Levofloxacin results in increased expression of CYP27A1 mRNA CTD PMID:24136188 Licochalcone B increases expression ISO RGD:1346613 6480464 licochalcone B results in increased expression of CYP27A1 mRNA CTD PMID:33647349 linalool increases expression ISO RGD:1346613 6480464 linalool results in increased expression of CYP27A1 mRNA CTD PMID:24752549 lithocholic acid multiple interactions ISO RGD:1550475 6480464 1 more ... CTD PMID:19196849 lithocholic acid decreases expression ISO RGD:1550475 6480464 Lithocholic Acid results in decreased expression of CYP27A1 mRNA CTD PMID:19196849 , PMID:20359477 melatonin multiple interactions ISO RGD:1550475 6480464 Melatonin inhibits the reaction [Ethanol results in increased expression of CYP27A1 mRNA] CTD PMID:28095641 metformin decreases expression ISO RGD:1550475 6480464 Metformin results in decreased expression of CYP27A1 mRNA CTD PMID:34058177 metformin multiple interactions ISO RGD:1550475 6480464 [Ethinyl Estradiol co-treated with Metformin] results in decreased expression of CYP27A1 mRNA, [Metformin co-treated with Ethinyl Estradiol] results in decreased expression of CYP27A1 protein CTD PMID:34058177 methamphetamine multiple interactions EXP 6480464 Valproic Acid inhibits the reaction [Methamphetamine results in decreased expression of CYP27A1 mRNA] CTD PMID:19149911 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of CYP27A1 mRNA CTD PMID:19149911 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of CYP27A1 mRNA CTD PMID:30467583 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of CYP27A1 mRNA CTD PMID:30047161 methotrexate increases expression ISO RGD:1346613 6480464 Methotrexate results in increased expression of CYP27A1 mRNA CTD PMID:19035488 , PMID:21232092 methotrexate multiple interactions ISO RGD:1346613 6480464 Methotrexate inhibits the reaction [IFNG protein results in decreased expression of CYP27A1 mRNA] more ... CTD PMID:19035488 methoxsalen decreases expression EXP 6480464 Methoxsalen results in decreased expression of CYP27A1 mRNA CTD PMID:28552422 methyltestosterone multiple interactions ISO RGD:1346613 6480464 [Methyltestosterone co-treated with Cholic Acids] affects the expression of CYP27A1 mRNA CTD PMID:27344345 metronidazole multiple interactions ISO RGD:1550475 6480464 [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA], [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA CTD PMID:36464106 morphine increases expression ISO RGD:1550475 6480464 Morphine results in increased expression of CYP27A1 mRNA CTD PMID:20144693 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of CYP27A1 mRNA CTD PMID:20360939 N-nitrosodiethylamine decreases expression ISO RGD:1550475 6480464 Diethylnitrosamine results in decreased expression of CYP27A1 mRNA CTD PMID:24535843 nefazodone multiple interactions ISO RGD:1346613 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of CYP27A1 mRNA CTD PMID:33819548 neomycin multiple interactions ISO RGD:1550475 6480464 [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA], [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA CTD PMID:36464106 nickel atom multiple interactions EXP 6480464 [nickel sulfate results in increased abundance of Nickel] which results in decreased expression of CYP27A1 mRNA CTD PMID:31734292 nickel atom decreases expression ISO RGD:1346613 6480464 Nickel results in decreased expression of CYP27A1 mRNA CTD PMID:25583101 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of CYP27A1 mRNA CTD PMID:22110744 nickel sulfate decreases expression ISO RGD:1346613 6480464 nickel sulfate results in decreased expression of CYP27A1 mRNA CTD PMID:20713136 nickel sulfate multiple interactions EXP 6480464 [nickel sulfate results in increased abundance of Nickel] which results in decreased expression of CYP27A1 mRNA CTD PMID:31734292 nickel sulfate increases expression ISO RGD:1346613 6480464 nickel sulfate results in increased expression of CYP27A1 mRNA CTD PMID:22714537 niclosamide increases expression ISO RGD:1346613 6480464 Niclosamide results in increased expression of CYP27A1 mRNA CTD PMID:36318118 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of CYP27A1 mRNA CTD PMID:24136188 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of CYP27A1 mRNA CTD PMID:33484710 NS-398 multiple interactions ISO RGD:1346613 6480464 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of CYP27A1 mRNA] more ... CTD PMID:19035488 NS-398 decreases expression ISO RGD:1346613 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of CYP27A1 mRNA, N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of CYP27A1 protein CTD PMID:19035488 obeticholic acid decreases expression ISO RGD:1346613 6480464 obeticholic acid results in decreased expression of CYP27A1 mRNA CTD PMID:27939613 oleanolic acid decreases expression ISO RGD:1550475 6480464 Oleanolic Acid results in decreased expression of CYP27A1 mRNA CTD PMID:23948738 oxycodone increases expression EXP 6480464 Oxycodone results in increased expression of CYP27A1 mRNA CTD PMID:23439660 ozone multiple interactions ISO RGD:1550475 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CYP27A1 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CYP27A1 mRNA CTD PMID:34911549 paracetamol affects expression ISO RGD:1550475 6480464 Acetaminophen affects the expression of CYP27A1 mRNA CTD PMID:17562736 paracetamol multiple interactions ISO RGD:1346613 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CYP27A1 mRNA CTD PMID:33819548 paracetamol multiple interactions ISO RGD:1550475 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in decreased expression of CYP27A1 mRNA] CTD PMID:29246445 paracetamol decreases expression ISO RGD:1550475 6480464 Acetaminophen results in decreased expression of CYP27A1 mRNA CTD PMID:29246445 paracetamol decreases expression ISO RGD:1346613 6480464 Acetaminophen results in decreased expression of CYP27A1 mRNA CTD PMID:21420995 more ... paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of CYP27A1 mRNA CTD PMID:32680482 perfluorodecanoic acid decreases expression ISO RGD:1550475 6480464 perfluorodecanoic acid results in decreased expression of CYP27A1 mRNA CTD PMID:27344344 perfluorodecanoic acid multiple interactions ISO RGD:1550475 6480464 PPARA protein affects the reaction [perfluorodecanoic acid results in decreased expression of CYP27A1 mRNA] CTD PMID:27344344 perfluorononanoic acid decreases expression ISO RGD:1550475 6480464 perfluoro-n-nonanoic acid results in decreased expression of CYP27A1 mRNA CTD PMID:29112762 perfluorononanoic acid decreases expression ISO RGD:1346613 6480464 perfluoro-n-nonanoic acid results in decreased expression of CYP27A1 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1550475 6480464 perfluorooctane sulfonic acid results in decreased expression of CYP27A1 mRNA CTD PMID:19429403 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1550475 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CYP27A1 mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CYP27A1 mRNA CTD PMID:36331819 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1346613 6480464 perfluorooctane sulfonic acid results in decreased expression of CYP27A1 mRNA CTD PMID:32253466 perfluorooctanoic acid decreases expression ISO RGD:1550475 6480464 perfluorooctanoic acid results in decreased expression of CYP27A1 mRNA CTD PMID:17681415 , PMID:19429403 perfluorooctanoic acid decreases expression ISO RGD:1346613 6480464 perfluorooctanoic acid results in decreased expression of CYP27A1 mRNA CTD PMID:32253466 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of CYP27A1 mRNA CTD PMID:19162173 phenobarbital multiple interactions ISO RGD:1550475 6480464 NR1I3 protein promotes the reaction [Phenobarbital inhibits the reaction [Lithocholic Acid results in decreased expression of CYP27A1 mRNA]], Phenobarbital inhibits the reaction [Lithocholic Acid results in decreased expression of CYP27A1 mRNA] CTD PMID:19196849 physcion decreases expression EXP 6480464 physcione results in decreased expression of CYP27A1 mRNA CTD PMID:28161596 pirinixic acid multiple interactions ISO RGD:1550475 6480464 NCF1 protein promotes the reaction [pirinixic acid results in decreased expression of CYP27A1 mRNA] CTD PMID:17950772 pirinixic acid decreases expression ISO RGD:1550475 6480464 pirinixic acid results in decreased expression of CYP27A1 mRNA CTD PMID:17950772 , PMID:23811191 pirinixic acid increases expression ISO RGD:1550475 6480464 pirinixic acid results in increased expression of CYP27A1 mRNA CTD PMID:17426115 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1550475 6480464 Pregnenolone Carbonitrile results in increased expression of CYP27A1 mRNA CTD PMID:28903501 procymidone affects expression ISO RGD:1550475 6480464 procymidone affects the expression of CYP27A1 mRNA CTD PMID:36764477 progesterone multiple interactions ISO RGD:1346613 6480464 CYP27A1 protein affects the metabolism of and affects the abundance of Progesterone CTD PMID:19671838 progesterone increases expression ISO RGD:1550475 6480464 Progesterone results in increased expression of CYP27A1 mRNA CTD PMID:22238285 progesterone multiple interactions ISO RGD:1550475 6480464 CYP27A1 protein affects the metabolism of and affects the abundance of Progesterone CTD PMID:19671838 prothioconazole increases expression ISO RGD:1550475 6480464 prothioconazole results in increased expression of CYP27A1 mRNA CTD PMID:36007749 Prothioconazole-desthio increases expression ISO RGD:1550475 6480464 prothioconazole-desthio results in increased expression of CYP27A1 mRNA CTD PMID:36007749 raloxifene affects expression EXP 6480464 Raloxifene Hydrochloride affects the expression of CYP27A1 mRNA CTD PMID:16079270 resveratrol increases expression ISO RGD:1550475 6480464 resveratrol results in increased expression of CYP27A1 mRNA CTD PMID:22610192 resveratrol increases expression ISO RGD:1346613 6480464 resveratrol results in increased expression of CYP27A1 mRNA, resveratrol results in increased expression of CYP27A1 protein CTD PMID:23041272 resveratrol multiple interactions ISO RGD:1346613 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol results in increased expression of CYP27A1 mRNA] more ... CTD PMID:23041272 rifampicin multiple interactions ISO RGD:1346613 6480464 Rifampin promotes the reaction [[NR1I2 protein binds to NCOA1 protein] which binds to CYP27A1 gene] CTD PMID:17088262 rifampicin increases expression ISO RGD:1346613 6480464 Rifampin results in increased expression of CYP27A1 mRNA CTD PMID:17088262 rotenone increases expression EXP 6480464 Rotenone results in increased expression of CYP27A1 mRNA CTD PMID:28374803 selenium atom multiple interactions ISO RGD:1550475 6480464 [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA] CTD PMID:36464106 Senkirkine decreases expression ISO RGD:1346613 6480464 senkirkine results in decreased expression of CYP27A1 mRNA CTD PMID:26100227 serpentine asbestos decreases methylation ISO RGD:1346613 6480464 Asbestos, Serpentine results in decreased methylation of CYP27A1 promoter CTD PMID:29626692 simvastatin multiple interactions EXP 6480464 Simvastatin promotes the reaction [Dietary Fats results in increased expression of CYP27A1 mRNA] CTD PMID:33383043 sirolimus multiple interactions ISO RGD:1346613 6480464 [Cyclosporine co-treated with Sirolimus] results in decreased activity of CYP27A1 protein CTD PMID:17516993 sirolimus decreases activity ISO RGD:1346613 6480464 Sirolimus results in decreased activity of CYP27A1 protein CTD PMID:17516993 sodium dodecyl sulfate decreases expression EXP 6480464 Sodium Dodecyl Sulfate results in decreased expression of CYP27A1 mRNA CTD PMID:12815608 streptozocin multiple interactions ISO RGD:1550475 6480464 [Dietary Fats co-treated with Streptozocin] results in decreased expression of CYP27A1 mRNA CTD PMID:29382564 sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of CYP27A1 mRNA CTD PMID:30047161 sunitinib decreases expression ISO RGD:1346613 6480464 Sunitinib results in decreased expression of CYP27A1 mRNA CTD PMID:31533062 Sunset Yellow FCF multiple interactions ISO RGD:1346613 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP27A1 mRNA CTD PMID:33819548 taurocholic acid decreases expression EXP 6480464 Taurocholic Acid results in decreased expression of CYP27A1 mRNA CTD PMID:7832767 tauroursodeoxycholic acid decreases expression EXP 6480464 ursodoxicoltaurine results in decreased expression of CYP27A1 mRNA CTD PMID:15885361 Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of CYP27A1 mRNA CTD PMID:21515302 testosterone decreases expression ISO RGD:1346613 6480464 Testosterone results in decreased expression of CYP27A1 mRNA CTD PMID:33359661 tetrachloroethene increases expression ISO RGD:1550475 6480464 Tetrachloroethylene results in increased expression of CYP27A1 mRNA CTD PMID:28973375 tetrachloromethane decreases expression ISO RGD:1550475 6480464 Carbon Tetrachloride results in decreased expression of CYP27A1 mRNA CTD PMID:17484886 more ... tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CYP27A1 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions ISO RGD:1550475 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of CYP27A1 mRNA CTD PMID:30517762 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYP27A1 mRNA] CTD PMID:31150632 tetracycline decreases expression ISO RGD:1550475 6480464 Tetracycline results in decreased expression of CYP27A1 mRNA CTD PMID:24489787 theophylline decreases expression EXP 6480464 Theophylline results in decreased expression of CYP27A1 protein CTD PMID:26851681 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of CYP27A1 mRNA CTD PMID:26222700 , PMID:34492290 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of CYP27A1 mRNA CTD PMID:33387578 triolein decreases expression ISO RGD:1550475 6480464 Triolein results in decreased expression of CYP27A1 mRNA CTD PMID:18356535 Triptolide decreases expression ISO RGD:1550475 6480464 triptolide results in decreased expression of CYP27A1 mRNA CTD PMID:32987112 tris(2-chloroethyl) phosphate decreases expression ISO RGD:1550475 6480464 tris(chloroethyl)phosphate results in decreased expression of CYP27A1 mRNA, tris(chloroethyl)phosphate results in decreased expression of CYP27A1 protein CTD PMID:35780845 tris(2-chloroethyl) phosphate multiple interactions ISO RGD:1550475 6480464 Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in decreased expression of CYP27A1 mRNA], Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in decreased expression of CYP27A1 protein] CTD PMID:35780845 trovafloxacin decreases expression ISO RGD:1550475 6480464 trovafloxacin results in decreased expression of CYP27A1 mRNA CTD PMID:35537566 uranium atom decreases activity EXP 6480464 Uranium results in decreased activity of CYP27A1 protein CTD PMID:16502312 uranium atom increases activity EXP 6480464 Uranium results in increased activity of CYP27A1 protein CTD PMID:16231126 , PMID:16502312 uranium atom decreases expression EXP 6480464 Uranium results in decreased expression of CYP27A1 mRNA CTD PMID:17118558 ursodeoxycholic acid increases expression EXP 6480464 Ursodeoxycholic Acid results in increased expression of CYP27A1 mRNA CTD PMID:16764892 ursodeoxycholic acid decreases expression ISO RGD:1550475 6480464 Ursodeoxycholic Acid results in decreased expression of CYP27A1 mRNA CTD PMID:25582706 valproic acid decreases expression ISO RGD:1346613 6480464 Valproic Acid results in decreased expression of CYP27A1 mRNA CTD PMID:29154799 valproic acid affects expression ISO RGD:1346613 6480464 Valproic Acid affects the expression of CYP27A1 mRNA CTD PMID:25979313 valproic acid multiple interactions EXP 6480464 Valproic Acid inhibits the reaction [Methamphetamine results in decreased expression of CYP27A1 mRNA] CTD PMID:19149911 vancomycin increases expression ISO RGD:1550475 6480464 Vancomycin results in increased expression of CYP27A1 mRNA CTD PMID:18930951 vancomycin multiple interactions ISO RGD:1550475 6480464 [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA], [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA CTD PMID:36464106 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of CYP27A1 mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of CYP27A1 mRNA CTD PMID:22570695 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of CYP27A1 mRNA CTD PMID:15671213 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of CYP27A1 mRNA CTD PMID:15671213 zymosterol increases metabolic processing ISO RGD:1346613 6480464 CYP27A1 protein results in increased metabolism of zymosterol CTD PMID:14622972
